LESD
MCID: LTT002
MIFTS: 33

Letterer-Siwe Disease (LESD)

Aliases & Classifications for Letterer-Siwe Disease

MalaCards integrated aliases for Letterer-Siwe Disease:

Name: Letterer-Siwe Disease 56 74 71
Histiocytosis X, Acute Disseminated 56
Histiocytosis, Langerhans-Cell 71
L-S Disease; Lesd 56
L-S Disease 56
Lesd 56

Characteristics:

OMIM:

56
Inheritance:
autosomal recessive


HPO:

31
letterer-siwe disease:
Inheritance autosomal recessive inheritance


Summaries for Letterer-Siwe Disease

MalaCards based summary : Letterer-Siwe Disease, also known as histiocytosis x, acute disseminated, is related to langerhans cell histiocytosis and hashimoto-pritzker syndrome, and has symptoms including fever The drugs Levoleucovorin and leucovorin have been mentioned in the context of this disorder. Affiliated tissues include bone, lung and lymph node, and related phenotypes are fever and dyspnea

Wikipedia : 74 Letterer-Siwe disease is one of the four recognized clinical syndromes of Langerhans cell histiocytosis... more...

More information from OMIM: 246400

Related Diseases for Letterer-Siwe Disease

Graphical network of the top 20 diseases related to Letterer-Siwe Disease:



Diseases related to Letterer-Siwe Disease

Symptoms & Phenotypes for Letterer-Siwe Disease

Human phenotypes related to Letterer-Siwe Disease:

31 (showing 15, show less)
# Description HPO Frequency HPO Source Accession
1 fever 31 HP:0001945
2 dyspnea 31 HP:0002094
3 irritability 31 HP:0000737
4 anemia 31 HP:0001903
5 pulmonary infiltrates 31 HP:0002113
6 abnormality of the skeletal system 31 HP:0000924
7 pallor 31 HP:0000980
8 thrombocytopenia 31 HP:0001873
9 jaundice 31 HP:0000952
10 seborrheic dermatitis 31 HP:0001051
11 neutropenia 31 HP:0001875
12 encephalopathy 31 HP:0001298
13 hepatosplenomegaly 31 HP:0001433
14 abdominal distention 31 HP:0003270
15 stomatitis 31 HP:0010280

Symptoms via clinical synopsis from OMIM:

56
Misc:
fever
onset in first year

Heme:
anemia
thrombocytopenia
neutropenia

Neuro:
encephalopathy
infantile irritability

Abdomen:
distended abdomen

Lab:
histiocytosis x (eosinophilic granuloma)
histiocytic infiltration of the liver, spleen and lymph nodes

Resp:
dyspnea

Skin:
pallor
jaundice
stomatitis
seborrhea
diffuse papulo-vesicular rash
more
G I:
hepatosplenomegaly

Radiology:
pulmonic infiltration
lytic osseous lesions

Clinical features from OMIM:

246400

UMLS symptoms related to Letterer-Siwe Disease:


fever

Drugs & Therapeutics for Letterer-Siwe Disease

Drugs for Letterer-Siwe Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 124, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Levoleucovorin Approved, Investigational Phase 3 68538-85-2
2
leucovorin Approved Phase 2, Phase 3 58-05-9 6006 143
3
Methotrexate Approved Phase 2, Phase 3 59-05-2, 1959-05-2 126941
4
Cytarabine Approved, Experimental, Investigational Phase 2, Phase 3 147-94-4, 65-46-3 6253
5
Cladribine Approved, Investigational Phase 2, Phase 3 4291-63-8 20279
6
Vincristine Approved, Investigational Phase 2, Phase 3 57-22-7, 2068-78-2 5978
7
Methylprednisolone Approved, Vet_approved Phase 2, Phase 3 83-43-2 6741
8
Mercaptopurine Approved Phase 2, Phase 3 50-44-2 667490
9
Prednisone Approved, Vet_approved Phase 2, Phase 3 53-03-2 5865
10
Prednisolone phosphate Approved, Vet_approved Phase 2, Phase 3 302-25-0
11
Methylprednisolone hemisuccinate Approved Phase 2, Phase 3 2921-57-5
12
Vinblastine Approved Phase 2, Phase 3 865-21-4 241903 13342
13
Indomethacin Approved, Investigational Phase 2, Phase 3 53-86-1 3715
14 Prednisolone acetate Approved, Vet_approved Phase 2, Phase 3 52-21-1
15
Prednisolone Approved, Vet_approved Phase 2, Phase 3 50-24-8 5755
16
Cyclophosphamide Approved, Investigational Phase 2, Phase 3 50-18-0, 6055-19-2 2907
17
Busulfan Approved, Investigational Phase 2, Phase 3 55-98-1 2478
18
Folic acid Approved, Nutraceutical, Vet_approved Phase 2, Phase 3 59-30-3 6037
19
Prednisolone hemisuccinate Experimental Phase 2, Phase 3 2920-86-7
20 Micronutrients Phase 3
21 Trace Elements Phase 3
22 Vitamins Phase 3
23 Antidotes Phase 3
24 Nutrients Phase 3
25 Protective Agents Phase 3
26 Vitamin B Complex Phase 2, Phase 3
27 Hormones Phase 2, Phase 3
28 Folic Acid Antagonists Phase 2, Phase 3
29 Folate Phase 2, Phase 3
30 Dermatologic Agents Phase 2, Phase 3
31 Antirheumatic Agents Phase 2, Phase 3
32 Vitamin B9 Phase 2, Phase 3
33 Antimetabolites Phase 3
34 Anti-Infective Agents Phase 2, Phase 3
35 Antiviral Agents Phase 2, Phase 3
36 Antineoplastic Agents, Hormonal Phase 2, Phase 3
37 Hormone Antagonists Phase 2, Phase 3
38 glucocorticoids Phase 2, Phase 3
39 Anti-Inflammatory Agents Phase 2, Phase 3
40 Analgesics, Non-Narcotic Phase 2, Phase 3
41 Analgesics Phase 2, Phase 3
42 Anti-Inflammatory Agents, Non-Steroidal Phase 2, Phase 3
43 Immunoglobulins Phase 2, Phase 3
44 2-chloro-3'-deoxyadenosine Phase 2, Phase 3
45 Antibodies Phase 2, Phase 3
46 Immunoglobulins, Intravenous Phase 2, Phase 3
47 Methylprednisolone Acetate Phase 2, Phase 3
48 Rho(D) Immune Globulin Phase 2, Phase 3
49 Cyclooxygenase Inhibitors Phase 2, Phase 3
50 Tubulin Modulators Phase 2, Phase 3
51 gamma-Globulins Phase 2, Phase 3
52 Tocolytic Agents Phase 2, Phase 3
53 Antimitotic Agents Phase 2, Phase 3
54 Immunologic Factors Phase 2, Phase 3
55 Immunosuppressive Agents Phase 2, Phase 3
56 Alkylating Agents Phase 2, Phase 3
57 Thymoglobulin Phase 2, Phase 3
58
Thioguanine Approved Phase 2 154-42-7 2723601
59
Etanercept Approved, Investigational Phase 2 185243-69-0
60
Iron Approved, Experimental Phase 2 15438-31-0, 7439-89-6 27284 23925
61
Deferasirox Approved, Investigational Phase 2 201530-41-8 5493381
62
Clotrimazole Approved, Vet_approved Phase 2 23593-75-1 2812
63
Miconazole Approved, Investigational, Vet_approved Phase 2 22916-47-8 4189
64
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 2 1177-87-3
65
Dexamethasone Approved, Investigational, Vet_approved Phase 2 50-02-2 5743
66
Vemurafenib Approved Phase 2 918504-65-1 23252090 42611257
67
Mebendazole Approved, Vet_approved Phase 2 31431-39-7 4030
68
Piperazine Approved, Vet_approved Phase 2 110-85-0 4837
69
Palbociclib Approved, Investigational Phase 2 571190-30-2 5005498 11431660 5330286
70
Olaparib Approved Phase 2 763113-22-0 23725625
71
Ivosidenib Approved, Investigational Phase 2 1448347-49-6 71657455
72
Mycophenolic acid Approved Phase 2 24280-93-1 446541
73
Denosumab Approved Phase 2 615258-40-7
74
Sirolimus Approved, Investigational Phase 2 53123-88-9 5284616 6436030 46835353
75
Lenograstim Approved, Investigational Phase 2 135968-09-1
76
Tacrolimus Approved, Investigational Phase 2 104987-11-3 445643 439492 6473866
77
rituximab Approved Phase 2 174722-31-7 10201696
78
Mechlorethamine Approved, Investigational Phase 2 51-75-2 4033
79
Lenalidomide Approved Phase 2 191732-72-6 216326
80
Fludarabine Approved Phase 2 21679-14-1, 75607-67-9 30751
81
Melphalan Approved Phase 2 148-82-3 460612 4053
82
alemtuzumab Approved, Investigational Phase 2 216503-57-0
83
Phenylalanine Approved, Investigational, Nutraceutical Phase 2 63-91-2 6140
84
Tyrosine Approved, Investigational, Nutraceutical Phase 2 60-18-4 6057
85 Ensartinib Investigational Phase 2 1370651-20-9
86
tipifarnib Investigational Phase 2 192185-72-1 159324
87 Neuroprotective Agents Phase 2
88 Calcium, Dietary Phase 2
89 acivicin Phase 2
90 Chelating Agents Phase 2
91 Iron Chelating Agents Phase 2
92 Antifungal Agents Phase 2
93 Cyclosporins Phase 2
94 Gastrointestinal Agents Phase 2
95 Antiemetics Phase 2
96 Anti-Bacterial Agents Phase 2
97 Protein Kinase Inhibitors Phase 2
98 Piperazine citrate Phase 2
99 DMP 777 Phase 2 157341-41-8
100 Poly(ADP-ribose) Polymerase Inhibitors Phase 2
101 Antitubercular Agents Phase 2
102 Calcineurin Inhibitors Phase 2
103 Antibiotics, Antitubercular Phase 2
104 Antilymphocyte Serum Phase 2
105 Adjuvants, Immunologic Phase 2
106 Antibodies, Monoclonal Phase 2
107 Nitrogen Mustard Compounds Phase 2
108 Angiogenesis Inhibitors Phase 2
109 Vaccines Phase 1, Phase 2
110 Antineoplastic Agents, Immunological Phase 2
111
Calcium Nutraceutical Phase 2 7440-70-2 271
112
L-Alanine Nutraceutical Phase 2 56-41-7 5950
113
Sunitinib Approved, Investigational Phase 1 557795-19-4, 341031-54-7 5329102
114
Somatostatin Approved, Investigational Phase 1 38916-34-6, 51110-01-1 53481605
115
Octreotide Approved, Investigational Phase 1 83150-76-9 383414 6400441
116 Pancreatic Polypeptide Investigational Phase 1 59763-91-6
117 Anti-Retroviral Agents Phase 1
118
Mesna Approved, Investigational 3375-50-6 598
119
Vidarabine Approved, Investigational 24356-66-9 21704 32326
120
Choline Approved, Nutraceutical 62-49-7 305
121 Insulin, Globin Zinc
122 insulin
123 Hypolipidemic Agents
124 Lipid Regulating Agents

Interventional clinical trials:

(showing 52, show less)
# Name Status NCT ID Phase Drugs
1 H-9926-LCH III: Treatment Protocol of the Third International Study for Langerhans Cell Histiocytosis Completed NCT00488605 Phase 3 Prednisone, Vinblastin, 6-mercaptopuroine;Leucovorin, Methotrexate, Vinblastine, Prednisone
2 LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis Recruiting NCT02205762 Phase 2, Phase 3 Prednisone;Vinblastine;mercaptopurine;INDOMETHACIN;Methotrexate;Cytosine Arabinoside;2-chlorodeoxyadenosine
3 Randomization of Cytarabine Monotherapy Versus Standard-of-Care Vinblastine/Prednisone for Frontline Treatment of Langerhans Cell Histiocytosis (TXCH LCH0115) Recruiting NCT02670707 Phase 3 Cytarabine;Vinblastine/prednisone
4 In-vivo T-cell Depletion and Hematopoietic Stem Cell Transplantation for Life-Threatening Immune Deficiencies and Histiocytic Disorders Terminated NCT00176826 Phase 2, Phase 3 Myeloablative conditioning regimen
5 The Use Of Umbilical Cord Blood As A Source Of Hematopoietic Stem Cells Unknown status NCT00084695 Phase 2 busulfan;cyclophosphamide;fludarabine phosphate;melphalan;methylprednisolone
6 Transplantation Using Umbilical Cord And Placental Blood Unknown status NCT00008164 Phase 2
7 Study of Sequential Administration of Oral 6-Thioguanine After Methotrexate in Patients With Langerhans Cell in Histiocytosis (LCH) Completed NCT00588536 Phase 2 Methotrexate;6-Thioguanine;Leucovorin Calcium
8 Efficacy and Tolerance of Combination Chemotherapy With Methotrexate and Cytosine Arabinoside in Newly Diagnosed Adult With Langerhans Cell Histiocytosis Completed NCT02389400 Phase 2 methotrexate
9 A Phase 2a, Open Label, Multicenter Study to Assess the Efficacy and Safety of the Oral AKT Inhibitor GSK2110183 in Subjects With Langerhans Cell Histiocytosis Completed NCT01395004 Phase 2 GSK2110183
10 Treatment of Resistant Langerhans Cell Histiocytosis With Etanercept (ENBREL, IMMUNEX, SEATTLE) Completed NCT00048373 Phase 2 Etanercept
11 Impact of Intervention With Deferasirox on the Immune Function of Patients With Hematologic Diseases and Transfusion-Related Iron Overload Completed NCT01273766 Phase 2 deferasirox
12 Allogeneic Hematopoietic Stem Cell Transplant for Patients With Immunologic or Histiocytic Disorders Using a Non-Myeloablative Preparative Regimen to Achieve Stable Mixed Chimerism Completed NCT00176865 Phase 2 Fludarabine;Melphalan;Anti-thymocyte globulin (ATG);Campath 1H;Cyclosporin A;Mycophenolate mofetil;Intravenous immunoglobulin (IVIG)
13 Phase II Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis and LCH-related Disorders Recruiting NCT02425904 Phase 2 Clofarabine
14 Cytarabine Monotherapy for Adult Patients With Newly Diagnosed Langerhans Cell Histiocytosis: A Single Arm, Single Center, Prospective Phase 2 Study Recruiting NCT04121819 Phase 2 Cytarabine
15 Thalidomide, Cyclophosphamide and Dexamethasone for Adult Patients With Recurrent/Refractory Langerhans Cell Histiocytosis: A Single Arm, Single Center, Prospective Phase 2 Study Recruiting NCT04120519 Phase 2 thalidomide combined with dexamethasone and cyclophosphamide
16 NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice)- Phase 2 Subprotocol of Vemurafenib in Patients With Tumors Harboring Braf V600 Mutations Recruiting NCT03220035 Phase 2 Vemurafenib
17 NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of Palbociclib in Patients With Tumors Harboring Activating Alterations in Cell Cycle Genes Recruiting NCT03526250 Phase 2 Palbociclib
18 NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice)- Phase 2 Subprotocol of Olaparib in Patients With Tumors Harboring Defects in DNA Damage Repair Genes Recruiting NCT03233204 Phase 2 Olaparib
19 NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of AG-120 (Ivosidenib) in Patients With Tumors Harboring IDH1 Mutations Recruiting NCT04195555 Phase 2 Ivosidenib
20 NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of LOXO-101 (Larotrectinib) in Patients With Tumors Harboring Actionable NTRK Fusions Recruiting NCT03213704 Phase 2 Larotrectinib;Larotrectinib Sulfate
21 NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice)- Phase 2 Subprotocol of Tazemetostat in Patients With Tumors Harboring Alterations in EZH2 or Members of the SWI/SNF Complex Recruiting NCT03213665 Phase 2 Tazemetostat
22 NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice)- Phase 2 Subprotocol of Ensartinib in Patients With Tumors Harboring ALK or ROS1 Genomic Alterations Recruiting NCT03213652 Phase 2 Ensartinib
23 NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of JNJ-42756493 (Erdafitinib) in Patients With Tumors Harboring FGFR1/2/3/4 Alterations Recruiting NCT03210714 Phase 2 Erdafitinib
24 NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of BVD-523FB (Ulixertinib) in Patients With Tumors Harboring Activating MAPK Pathway Mutations Recruiting NCT03698994 Phase 2 Ulixertinib
25 Evaluation of Efficacy of Denosumab in Adult Patients With Langerhans Cell Histiocytosis (LCH): a Multiple-site, Single Arm, Open Label Clinical Trial Recruiting NCT03270020 Phase 2 Denosumab 70 MG/ML [Xgeva]
26 NCI-COG Pediatric MATCH (Molecular Analysis For Therapy Choice)- Phase 2 Subprotocol of LY3023414 in Patients With Solid Tumors Recruiting NCT03213678 Phase 2 Samotolisib
27 Cord Blood Ex-Vivo MSC Expansion Plus Fucosylation to Enhance Homing and Engraftment Recruiting NCT03096782 Phase 2 Busulfan;Clofarabine;Cyclophosphamide;Fludarabine;Melphalan;Mycophenolate Mofetil;Tacrolimus
28 The Prospective Non-randomized Phase II Clinical Trial of Vemurafenib in Combination With Cytarabine and 2-chlorodeoxyadenosine in Children With Langerhans-cell Hisitocytosis With BRAF V600E Mutation Recruiting NCT03585686 Phase 2 Vemurafenib;Cytarabine;2-chlorodeoxyadenosine
29 NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol Recruiting NCT03155620 Phase 2 Ensartinib;Erdafitinib;Larotrectinib;Olaparib;Palbociclib;Samotolisib;Selpercatinib;Selumetinib Sulfate;Tazemetostat;Tipifarnib;Ulixertinib;Vemurafenib
30 Evaluation of Efficacy and Tolerance of Cladribine in Symptomatic Patients With Pulmonary Langerhans Cell Histiocytosis and Impairment of Lung Function Active, not recruiting NCT01473797 Phase 2 Cladribine
31 A Phase II Study of Lenalidomide for Adult Histiocyte Disorders Active, not recruiting NCT02523040 Phase 2 Lenalidomide
32 CD34+ Stem Cell Selection for Patients Receiving a Matched or Partially Matched Family or Unrelated Adult Donor Allogeneic Stem Cell Transplantation for Non-Malignant Disease Active, not recruiting NCT01966367 Phase 1, Phase 2
33 NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of LOXO-292 in Patients With Tumors Harboring RET Gene Alterations Not yet recruiting NCT04320888 Phase 2 Selpercatinib
34 NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice)- Phase 2 Subprotocol of Tipifarnib in Patients With Tumors Harboring HRAS Genomic Alterations Not yet recruiting NCT04284774 Phase 2 Tipifarnib
35 A Phase 2 Study to Assess the Safety and Efficacy of Cobimetinib in Refractory Langerhans Cell Histiocytosis, LCH-Associated Neurodegenerative Disease, and Other Histiocytic Disorders. Not yet recruiting NCT04079179 Phase 2 Cobimetinib
36 Reduced Intensity Hematopoietic Cell Transplantation for Patients With Resistant Langerhans Cell Histiocytosis Terminated NCT00618540 Phase 2 fludarabine phosphate;melphalan
37 Phase II Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis Withdrawn NCT01796405 Phase 2 Clofarabine
38 A Phase 1/Pharmacokinetic Study of Sunitinib in Patients With Cancer Who Also Have HIV and Are on HAART Therapy Completed NCT00890747 Phase 1 sunitinib malate
39 A Phase I Study of [111In-DTPA-D-Phe]-Octreotide in Patients With Refractory Malignancies Expressing Somatostatin Receptors Terminated NCT00002947 Phase 1
40 Functional and Genetical Characterization of Pulmonary Langerhans Cell Histiocytosis: Diagnostic and Therapeutical Implications. Unknown status NCT03093727
41 Assessment of Safety of Air Travel in Patients With Pulmonary Langerhans Cell Histiocytosis Unknown status NCT03052101
42 CARDIOVASCULAR RISK FACTORS IN ADULT PATIENTS WITH MULTISYSTEM LANGERHANS-CELL HISTIOCYTOSIS: EVIDENCE OF GLUCOSE METABOLISM ABNORMALITIES Unknown status NCT00483925
43 Pilot Study to Determine Uptake and Biodistribution of 18F-fluorocholine in Histiocytic Disorders by PET Imaging and Biopsy Measurement Completed NCT02608619
44 Epidemiology of Adult Adult Pulmonary Langerhans Cell Histiocytosis - A Multicenter Cohort Study Completed NCT01225601
45 Evaluation of Outcome of Adult Pulmonary Langerhans Cell Histiocytosis Based on Lung HRCT and Lung Function. A Multicenter Retrospective Study Completed NCT01651507
46 Establishing Continuous Cell Lines and Xenografts From Pediatric Cancers for Biological and Pre-Clinical Therapeutic Studies Completed NCT00898755
47 Treatment Protocol of the Third International Study For Langerhans Cell Histiocytosis Completed NCT00276757 leucovorin calcium;methotrexate;prednisolone;vinblastine sulfate
48 Evaluation of Exercise Capacity and Mechanisms of Exercise Limitation in Patients With Pulmonary Langerhans Cell Histiocytosis Completed NCT02665546
49 Inherited Genetic Susceptibility in Langerhans Cell Histiocytosis (LCH) Recruiting NCT04100408
50 The Project: EveryChild Protocol: A Registry, Eligibility Screening, Biology and Outcome Study Recruiting NCT02402244
51 Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies Recruiting NCT01652092 Alemtuzumab 0.3 mg;Cyclophosphamide;Busulfan;Fludarabine phosphate 40 mg;Melphalan;Alemtuzumab 0.2 mg;Busulfan;Fludarabine phosphate 30 mg;MESNA
52 The Use Of Peripheral Blood Stem Cells For Allogeneic Transplantation Terminated NCT00008216

Search NIH Clinical Center for Letterer-Siwe Disease

Inferred drug relations via UMLS 71 / NDF-RT 50 :


Thalidomide

Genetic Tests for Letterer-Siwe Disease

Anatomical Context for Letterer-Siwe Disease

MalaCards organs/tissues related to Letterer-Siwe Disease:

40
Bone, Lung, Lymph Node, Liver, Skin, Spleen, T Cells

Publications for Letterer-Siwe Disease

Articles related to Letterer-Siwe Disease:

(showing 352, show less)
# Title Authors PMID Year
1
Familial occurrence of Letterer-Siwe disease. 61 56
5018627 1972
2
U.S. mortality from Letterer-Siwe disease, 1960-1964. 61 56
5663744 1968
3
FAMILIAL OCCURRENCE OF LETTERER-SIWE DISEASE. 56 61
14084326 1963
4
Familial Letterer-Siwe disease. Report of a case. 61 56
14037540 1962
5
Langerhans cell histiocytosis. 56
7608790 1995
6
Familial occurrence of histiocytosis. 56
300046 1977
7
Familial pulmonary histiocytosis-X. 56
4695633 1973
8
Genetic determination of acute disseminated histiocytosis X. 56
5444399 1970
9
A unique manifestation of Langerhans cell histiocytosis: Diagnostic and therapeutic considerations of atypical cases. 61
29940687 2018
10
Multidisciplinary approach in a case of Hand-Schüller-Christian disease with maxillary involvement. 61
29418009 2018
11
"Histiocytosis X" - A Rare Case Report. 61
27891484 2016
12
Gastrointestinal: Letterer Siwe disease: An uncommon gastrointestinal presentation. 61
26757250 2016
13
Congenital self-healing reticulohistiocytosis: an underreported entity. 61
27163913 2016
14
Localized Langerhans cell histiocytosis masquerading as Brodie's abscess in a 2-year-old child: a case report. 61
27065773 2016
15
Solitary extragnathic langerhans cell histiocytosis - a rare case. 61
25954715 2015
16
Solitary eosinophilic granuloma of mandibular condyle: literature review and report of a rare case. 61
25861187 2015
17
Langerhans-cell histiocytosis (LCH) a presentation of two siblings with two different entities. 61
26191478 2015
18
Hand schuller christian disease: a rare case report with oral manifestation. 61
25738095 2015
19
Diagnosis and management of langerhans cell histiocytosis. 61
25281259 2014
20
A rare occurrence of Langerhans cell histiocytosis in an adult. 61
25948998 2014
21
Narrowband ultraviolet B light in Langerhans cell histiocytosis: a case report. 61
24224945 2014
22
29 year-old male with seizure and syncope. Intracerebral Langerhans cell histiocytosis. 61
23587144 2013
23
[Letterer Siwe disease in an adult: a case report]. 61
23336233 2012
24
A rare case of langerhans cell histiocytosis of the gastrointestinal tract. 61
22493557 2012
25
Operative case of Langerhans'cell histiocytosis of the skull with dural invasion. An immunohystochemical study of ki-67 expression of eosinophilic granuloma: case report and review of the literature. 61
22415385 2012
26
Eosinophilic granuloma: resolution of lesion after biopsy. 61
22134295 2011
27
Letterer-Siwe disease associated with chronic myelomyonocytic leukemia: a fortuitous association? 61
20372775 2010
28
Analysis of histiocytosis deaths in the US and recommendations for incidence tracking. 61
21688746 2010
29
[Langerhans cell histiocytosis]. 61
19828161 2009
30
Oral Langerhans cell histiocytosis in Malaysian children: a 40-year experience. 61
19486369 2009
31
[Langerhans cell histiocytosis: Letterer-Siwe disease - the importance of dermatological diagnosis in two cases]. 61
19851674 2009
32
Langerhans cell histiocytosis, a case of Letterer Siwe disease. 61
19785312 2009
33
Langerhans cell histiocytosis: literature review and descriptive analysis of oral manifestations. 61
19218906 2009
34
Langerhans cell histiocytosis presented as bilateral otitis media and mastoiditis. 61
18365596 2008
35
[Clinical and pathologic features of Letterer-Siwe disease: a case report and review]. 61
18072575 2007
36
A case report of langerhans histiocytosis presenting sequentially over a 21-year period with Letterer-Siwe disease, hand-Schuller-Christian disease and eosinophillic granuloma of bone. 61
17114962 2006
37
Disseminated crusted papules in a newborn. 61
16875431 2006
38
Splenic infarction in Letterer-Siwe disease. 61
15910461 2005
39
Spontaneous regression of supratentorial intracerebral Langerhans' cell histiocytosis. 61
15326050 2004
40
Congenital self-healing reticulohistiocytosis: report of a case and review of the literature. 61
15124855 2004
41
[One neonatal patient with letterer-siwe disease]. 61
14751071 2003
42
Quiz. Langerhans cell histiocytosis (Letterer-Siwe disease). 61
17642901 2003
43
[Eosinophilic granuloma of the temporal bone. Case report and literature review]. 61
12717600 2003
44
Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. 61
12121233 2002
45
Bilateral multifocal uveal juvenile xanthogranuloma in a young boy with systemic disease. 61
12107521 2002
46
Self-healing congenital Langerhans cell histiocytosis presenting as neonatal papulovesicular eruption. 61
11907857 2001
47
Letterer siwe disease. 61
17664795 2001
48
Langerhans cell histiocytosis of the thyroid gland. A case report. 61
11015983 2000
49
Histiocytosis of the temporal bone. 61
23119694 2000
50
Electron microscopic study of Langerhans cell histiocytosis. 61
10935343 2000
51
[Self-healing Hashimoto-Pritzker histiocytosis]. 61
10911529 2000
52
[Pneumothorax secondary to pulmonary histiocytosis X]. 61
10528489 1999
53
Langerhans cell histiocytosis research. Past, present, and future. 61
9561908 1998
54
Birbeck granules: contribution to the comprehension of intracytoplasmic evolution. 61
9648293 1998
55
Langerhans cell histiocytosis presenting as bilateral eosinophilic granulomata in the molar region of the mandible. A case report. 61
9565287 1998
56
Diagnostic dilemmas in pediatric/adolescent dermatology: scaly scalp. 61
9592441 1998
57
[Letterer-Siwe disease]. 61
9851167 1998
58
[Histiocytosis X with mandibular involvement. Apropos of a case]. 61
9273674 1997
59
Letterer-Siwe disease with bilateral temporal bone involvement. 61
9006683 1997
60
[Langerhans cell histiocytosis of lymph node]. 61
9063934 1996
61
Langerhans cell histiocytosis associated with partial DiGeorge syndrome in a newborn. 61
8888752 1996
62
Langerhans' cell histiocytosis. 61
8649742 1996
63
Langerhans cell (eosinophilic) granulomatosis. A clinicopathologic study encompassing 50 years. 61
8619419 1996
64
[Report of a rare case of Langerhans-cell histiocytosis of the skull base]. 61
8668295 1996
65
Langerhans cell histiocytosis in monocygote twins: case reports. 61
8692432 1996
66
[Histiocytosis]. 61
8977972 1996
67
Perirenal mass of Langerhans cell histiocytosis. 61
7720738 1995
68
[Langerhans cell histiocytosis]. 61
7892011 1995
69
Langerhans cell histiocytosis. 61
20952874 1995
70
Congenital "self-healing" Langerhans cell histiocytosis: the need for long-term follow-up. 61
7962747 1994
71
Langerhans cell histiocytosis: a 10-year review. 61
7942024 1994
72
[Hashimoto-Pritzker self-healing reticulohistiocytosis and congenital histiocytosis]. 61
7994350 1994
73
Pregnancy in a patient with eosinophilic granulomatosis of the lung: a case report. 61
8159358 1994
74
Central nervous system histiocytosis X--imaging and responses to chemotherapy. 61
8290941 1993
75
[A histiocytosis X without histological findings: a new entity of histiocytosis X]. 61
8434175 1993
76
Congenital histiocytosis X. 61
8332403 1993
77
Expression of neuron-specific enolase immunoreactivity by cutaneous and extracutaneous Langerhans-cell histiocytoses ("X"). 61
1293186 1992
78
Langerhans cell histiocytosis of bone. 61
1636041 1992
79
[Congenital cutaneous Langerhans histiocytosis. Apropos of 7 cases]. 61
1605506 1992
80
Congenital self-healing histiocytosis. Report of two cases with histochemical and ultrastructural studies. 61
1951985 1991
81
Langerhans cell histiocytosis in monozygotic twins. 61
1999526 1991
82
Enhanced expression of c-myc and H-ras oncogenes in Letterer-Siwe disease. A sequential study using colorimetric in situ hybridization. 61
2252422 1990
83
Congenital Letterer-Siwe disease with intrauterine fetal death: a case report and review of the literature. 61
1982543 1990
84
[Pathologic fracture disclosing Letterer-Siwe disease in adults]. 61
2218364 1990
85
[Recurrent intertrigo as initial manifestation of histiocytosis X]. 61
2214927 1990
86
[Histiocytosis X. Letterer-Siwe disease]. 61
2195795 1990
87
Eosinophilic granuloma of the temporal bone: radiological approach in the pediatric patient. 61
2216591 1990
88
Letterer-Siwe disease and subacute monocytic leukemia. 61
2808842 1989
89
Letterer-Siwe disease in adults. 61
2642729 1989
90
Bone marrow monocytes in histiocytosis X acquire some phenotypic features of Langerhans cells in long term bone marrow cultures. 61
2479166 1989
91
Precocious tooth eruption and loss in Letterer-Siwe disease. 61
3214622 1988
92
Letterer-Siwe disease: immunopathologic study with a new monoclonal antibody. 61
3259591 1988
93
Letterer-Siwe disease (histiocytosis-X) (a case report). 61
3262156 1988
94
Letterer-Siwe disease: immunohistochemical evidence for a proliferative disorder involving immature cells of Langerhans lineage. 61
3135661 1988
95
[Letterer-Siwe disease]. 61
3213221 1988
96
[Letterer-Siwe disease]. 61
3423679 1987
97
Histiocytosis X: overlapping form between Letterer-Siwe disease and Hand-Schüller-Christian disease with advanced thymic involvement and obstructive jaundice. 61
3497999 1987
98
Skin scrapping in the diagnosis of Letterer-Siwe disease. 61
3679480 1987
99
Giant cell pneumonia in Letterer-Siwe disease. 61
3618221 1987
100
Letterer-Siwe disease in an adult. 61
3829721 1987
101
Lymphohistiocytosis in childhood. Pathologic comparison with fatal Letterer-Siwe disease (disseminated visceral histiocytosis X). 61
3822757 1987
102
Differential diagnosis of unusual skin diseases in infants. 61
3110751 1987
103
A child with Letterer Siwe disease. 61
3774344 1986
104
Magnetic resonance imaging of inflammatory lung disorders: preliminary studies in children. 61
3763258 1986
105
Ultrastructural observation of Charcot-Leyden crystals in mechlorethamine-treated cutaneous lesions of histiocytosis X. 61
3485666 1986
106
[Letterer-Siwe disease in half-brothers]. 61
3827626 1986
107
Specific cutaneous manifestations of internal malignancy. 61
3079247 1986
108
Peanut agglutinin. A useful marker for histiocytosis X and interdigitating reticulum cells. 61
2417675 1986
109
Histiocytosis X: otologic presentations. 61
3878341 1985
110
Primary eosinophilic granuloma of frontal lobe. Diagnostic use of S-100 protein. 61
3891065 1985
111
Letterer-Siwe disease in the ninth decade. 61
3973131 1985
112
Benign isolated histiocytosis mimicking chicken pox in a neonate: report of two cases with ultrastructural study. 61
4034439 1985
113
[Histiocytic proliferative diseases]. 61
3907602 1985
114
[Histiocytosis X. 3 different cases: eosinophilic granuloma, Hand-Schueller-Christian disease, Abt-Letterer-Siwe disease]. 61
3842238 1985
115
Lectin I of Ulex europaeus as a marker for a subset of histiocytic tumours of the lymph node. 61
3936262 1985
116
[Abt-Letterer-Siwe disease, combined with spastic disorders of the Little type]. 61
6528694 1984
117
Generalized histiocytosis X in the elderly: a light and electron microscope and monoclonal antibody study. 61
6396195 1984
118
Multifocal eosinophilic granuloma: a clinical pathologic conference. 61
6434715 1984
119
Histiocytosis X: rate and pattern of resolution of osseous lesions. 61
6611563 1984
120
Histiocytosis X of the head and neck. 61
6611470 1984
121
Acute disseminated histiocytosis-X: in situ immunophenotyping with monoclonal antibodies. 61
6365987 1984
122
Spontaneous remission of multi-system histiocytosis X. 61
6142997 1984
123
Orbital infiltration in Letterer-Siwe disease. 61
6690498 1984
124
Letterer-Siwe disease in an octogenarian. 61
6546937 1984
125
Letterer-Siwe disease. 61
6679501 1983
126
Eosinophilic granuloma in the temporal bone and skull. 61
6415580 1983
127
Histiocytosis X. 61
6347865 1983
128
Letterer-Siwe disease with nail involvement. 61
6851645 1983
129
Ultrastructural study of Letterer-Siwe disease in three infants, one complicated by pneumocystosis. 61
6336297 1983
130
Malignant histiocytosis and Letterer-Siwe disease. Neoplasms of T-zone histiocyte with S100 protein. 61
6687444 1983
131
[Hypothalamic histiocytosis X--report of a case]. 61
6602949 1983
132
S-100 protein in Langerhans cells, interdigitating reticulum cells and histiocytosis X cells. 61
6982186 1982
133
Letterer-Siwe disease: a study of thirteen cases over a 21 - year period. 61
7059511 1982
134
[Histiocytosis X]. 61
7082203 1982
135
Cerebrospinal fluid cytology in histiocytic proliferative disorders. 61
6175126 1982
136
[Self-healing childhood histiocytosis X (Illig-Fanconi disease). Comments on ultrastructural aspects and etiopathogenic classification of histiocytosis]. 61
6764232 1982
137
An ultrastructural and immunohistochemical study on mandibular lesion of Letterer-Siwe disease. 61
6801234 1981
138
[Acute disseminated form of histiocytosis X (Abt-Letterer-Siwe disease)]. 61
7195955 1981
139
Prostaglandins in histiocytosis-X. PG synthesis by histiocytosis-X cells. 61
6970520 1981
140
[Congenital Letterer-Siwe disease]. 61
7325826 1981
141
Familial lymphohistiocytosis. 61
7327433 1981
142
Congenital Letterer-Siwe disease associated with protein losing enteropathy. 61
7449792 1980
143
Liver lipids in Letterer-Siwe disease. 61
7449795 1980
144
[Congenital histiocytosis X. Papulo-nodal necrotic form]. 61
6993425 1980
145
Eosinophilic granuloma of bone. 61
6999317 1980
146
Letterer-Siwe disease in an elderly patient: histological and ultrastructural findings. 61
535172 1979
147
The pathology of adult type Letterer-Siwe disease. 61
535171 1979
148
Letterer-Siwe disease in the adult. 61
535170 1979
149
Histiocytosis X of the ear and temporal bone: review of 22 cases. 61
315504 1979
150
[Oral manifestations of Letterer-Siwe disease]. 61
297563 1979
151
Letterer Siwe disease--report of a case. 61
541095 1979
152
[Letterer-Siwe disease in combination with intravascular hemolysis in a nursing infant]. 61
471674 1979
153
A review of histiocytosis X with particular reference to eosinophilic granuloma of the lung. 61
391779 1979
154
[Oral manifestations of Letterer-Siwe disease. Clinical and histological study of lesions centered in the mouth of a infant with acute and disseminated histiocytosis X]. 61
316185 1979
155
Letterer-Siwe disease with lipid-containing vacuolated cells--an autopsy case. 61
735815 1978
156
Idiopathic differentiated histiocytosis. 61
309279 1978
157
[Letterer-Siwe disease as the terminal stage of a multifocal eosinophilic granuloma. Clinical, histopathological and nosographic study]. 61
692505 1978
158
Letterer-Siwe disease. Presentation as an otologic problem. 61
672366 1978
159
[Abt-Letterer-Siwe disease. Diagnosis and therapy (author's transl)]. 61
672908 1978
160
A 9-year observation of Letterer-Siwe disease in a child with long-term maintenance of remission. 61
685680 1978
161
Posterior choroidal involvement in Letterer-Siwe disease. 61
739337 1978
162
Histiocytosis and a leukaemoid response. A case report. 61
276942 1978
163
[2 cases of reticulohistiocytosis]. 61
629653 1978
164
[Long-term observation of a child with a second remission of Letterer-Siwe disease]. 61
604846 1977
165
[Histiocytosis X. Letterer-Siwe disease]. 61
304598 1977
166
Letterer-Siwe disease: a caring case study. 61
271915 1977
167
Eosinophilic granuloma and its variations. 61
917473 1977
168
Electron microscopic study of the orbital lesion of Hand-Schüller-Christian disease. 61
302326 1977
169
Letterer-Siwe disease: report of case. 61
330581 1977
170
A Chinese girl with features of Letterer-Siwe disease, histiocytic medullary reticulosis and monocytic leukaemia. 61
270819 1977
171
[Letterer-Siwe disease in adults with ungual lesions]. 61
921119 1977
172
Mitotic histiocytes and intranuclear Langerhans cell granules in histiocytosis X. 61
194391 1977
173
Histiocytosis X: late manifestations in a long-term survivor of Letterer-Siwe disease. 61
1086897 1976
174
Systemic giant-cell histiocytosis: report of a case and a review of the adult form of Letterer-Siwe disease. 61
793710 1976
175
[Acute reticulohistiocytosis, Letterer-Siwe disease, in an 11-month-old infant]. 61
951100 1976
176
Letter: Hypofibrinogenemia in Letterer-Siwe disease and in familial hemophagocytic reticulosis. 61
1151539 1975
177
[Proceedings: Letterer-Siwe disease. Profuse cutaneous form. Ultrastructural study]. 61
1182000 1975
178
[Letterer-Siwe disease]. 61
1163341 1975
179
Letterer-Siwe disease. 61
4438301 1974
180
Congenital Letterer-Siwe disease. 61
4838016 1974
181
[A case of Letterer-Siwe disease]. 61
4465269 1974
182
Hypofibrinogenemia in histiocytosis X, type Letterer-Siwe disease. 61
4785155 1973
183
Letterer-Siwe disease in a young adult. 61
4743434 1973
184
[Probable spontaneous remission in a 20-month-old girl with Abt-Letterer-Siwe disease]. 61
4753952 1973
185
Clinical manifestations of Letterer-Siwe disease in the neonatal period. 61
4703027 1973
186
Ocular involvement in Letterer-Siwe disease. 61
4697182 1973
187
[Abt-Letterer-Siwe disease in an infant]. 61
4689201 1973
188
The oncogenicity of cell cultures isolated from normal subjects and from patients with infectious mononucleosis, Letterer-Siwe disease or Hodgkin disease. 61
4631773 1973
189
Oral manifestations of Letterer-Siwe disease. 61
5034676 1972
190
[Letterer-Siwe disease]. 61
4657100 1972
191
A benign form of Letterer-Siwe disease. 61
5146930 1971
192
Bone change in Letterer-Siwe disease. 61
5131714 1971
193
Treatment of Letterer-Siwe disease. 61
5565470 1971
194
Letterer-Siwe disease. Report of a case. 61
5133088 1971
195
[Letterer-Siwe disease]. 61
5564723 1971
196
Skin ultrastructure in Letterer-Siwe disease treated with vinblastine. Mode of penetration of Langerhans granules into the nucleus. 61
5575200 1971
197
[Anatomo-clinical study of 2 cases of Letterer-Siwe disease]. 61
5553904 1971
198
Langerhans cell granulein Letterer-Siwe disease. An electron microscopic study. 61
5476789 1970
199
[Letterer-Siwe disease with initial oral symptomatology]. 61
5278241 1970
200
Successful treatment of an infant with Letterer-Siwe disease with vinblastine sulfate. 61
5454671 1970
201
Letterer-Siwe disease. Report of six cases. 61
5452682 1970
202
[Abt-Letterer-Siwe disease]. 61
5510720 1970
203
[Letterer-Siwe disease]. 61
5205539 1970
204
Letterer-Siwe disease and eosinophilic granuloma. Case report including the ultrastructural findings of the histiocytes proliferating in these disorders. 61
5396118 1969
205
Osmium zinc iodide reactive sites in the epidermal Langerhans cell. 61
4186413 1969
206
[Letterer-Siwe disease in the framework of reticuloendotheliosis. Histopathogenetic aspects]. 61
5402900 1969
207
[Endogenous eczema as an erroneous diagnosis in Abt-Letterer-Siwe disease]. 61
5355986 1969
208
Acute disseminated histiocytosis X: a case with transition from eosinophilic granuloma of bone to Letterer-Siwe disease. 61
5793702 1969
209
[Relationship of the concept of Abt-Letterer-Siwe disease and histiocytosis X]. 61
5784462 1969
210
Cutaneous Letterer-Siwe disease. 61
5763834 1969
211
[Abt-Letterer-Siwe disease with agammaglobulinemia A and M in an 18-month-old child]. 61
5713191 1968
212
Congenital Letterer-Siwe disease. A case treated with vincristine and corticosteroids. 61
5687488 1968
213
[Histiocytosis X eosinophilic granuloma, Hand-Schüller-Christian disease, Letterer-Siwe disease]. 61
4976530 1968
214
[Histiocytic reticulosis in infants or Letterer-Siwe disease. (Clinical and therapeutical study)]. 61
4976577 1968
215
A case report of congenital Letterer--Siwe disease. 61
5246445 1968
216
[A contribution on the Letterer-Siwe disease]. 61
5683828 1968
217
Letterer-Siwe disease. 61
5240678 1968
218
[Letterer-Siwe disease of prolonged and apparently favorable development]. 61
5677920 1968
219
Cutaneous lesions of Letterer-Siwe disease. Electron microscopic study. 61
6061632 1967
220
[Osseous lesions of histiocytosis-X (eosinophilic granuloma of bone; Hand-Schueller-Christian disease; Letterer-Siwe disease)]. 61
6071109 1967
221
Letterer-Siwe disease. 61
6025576 1967
222
[Letterer Siwe disease; initial form; evolution]. 61
5582191 1967
223
Chorio-retinal degeneration of the pigmentary type in the Abt-Letterer-Siwe disease. 61
6030898 1967
224
[Dysontogenetic reticuloendotheliosis in the newborn with leukemic manifestation, a variation of the Letterer-Siwe disease]. 61
5589142 1967
225
Letterer-Siwe disease. A survey and a review of the course in two subchronic cases. 61
5582374 1967
226
Letterer-Siwe disease. Report of a case. 61
5224180 1966
227
Letterer-Siwe disease or acute histiocytosis X. A case report. 61
5297236 1966
228
[Oral manifestations of the Abt-Letterer-Siwe disease]. 61
5225409 1966
229
[Remarks on a case of Letterer-Siwe disease in a pair of twins]. 61
5990436 1966
230
[Observations on a rare case of reticuloendotheliosis characterized by a picture of "pneumoreticulosis bullosa" with associated symptoms of Abt-Letterer-Siwe disease and Hand-Schüller-Christian disease]. 61
5915698 1966
231
Apparent cure of Letterer-Siwe disease. Seventeen-year survival of identical twins with nonlipoid reticuloendotheliosis. 61
5952210 1966
232
Letterer-Siwe disease in a newborn. 61
5905216 1966
233
[On a case of Abt-Letterer-Siwe disease]. 61
5860654 1965
234
Letterer-Siwe disease. Report of a case emphasizing effective corticosteroid therapy. 61
5844401 1965
235
[Abt-Letterer-Siwe disease]. 61
5850302 1965
236
Letterer-siwe disease. 61
5835343 1965
237
[A case of congenital Letterer-Siwe disease. Treatment with prednisone. Terminal superinfection with Pneumocystis carinii]. 61
5295171 1965
238
[On corticoid therapy of the Letterer-Siwe disease]. 61
5838626 1965
239
[Letterer-Siwe disease. A review and study of its course in 2 subchronic cases]. 61
5869252 1965
240
[The Abt-Letterer-Siwe disease. Case contribution]. 61
5861170 1965
241
[PROGNOSIS AND PRESENT THERAPY OF THE ABT-LETTERER-SIWE DISEASE]. 61
14306927 1965
242
[HISTOCHEMISTRY OF THE LIPIDS IN THE RETICULOHISTIOCYTES IN A CASE OF LETTERER-SIWE DISEASE]. 61
14262138 1965
243
[REMARKABLE ACTION OF CORTICOTHERAPY IN A SEVERE CASE OF LETTERER-SIWE DISEASE]. 61
14308207 1965
244
[LETTERER-SIWE DISEASE. FAVORABLE COURSE AFTER GAMMA-GLOBULIN THERAPY]. 61
14308206 1965
245
[Electron microscope findings on lymph node structure in the course of the Abt-Letterer-Siwe disease]. 61
5829048 1964
246
[APROPOS OF 2 CASES OF ABT-LETTERER-SIWE DISEASE]. 61
14188082 1964
247
[ON A CASE OF ABT-LETTERER-SIWE DISEASE]. 61
14298713 1964
248
LETTERER-SIWE DISEASE. REPORT OF A CASE. 61
14116900 1964
249
HISTIOCYTOSIS X (EOSINOPHILIC GRANULOMA OF BONE, LETTERER-SIWE DISEASE, AND SCHUELLER-CHRISTIAN DISEASE). FURTHER OBSERVATIONS OF PATHOLOGICAL AND CLINICAL IMPORTANCE. 61
14104316 1964
250
[Congenital Letterer-Siwe disease]. 61
14018565 1963
251
E.N.T. manifestations in Letterer-Siwe disease. 61
13993752 1963
252
[CONSIDERATIONS ON THE COURSE OF ABT-LETTERER-SIWE DISEASE]. 61
14123538 1963
253
[Malignant subacute reticuloendotheliosis of childhood, Letterer-Siwe disease, studied as a generalized candidisis]. 61
13898320 1962
254
Congenital Letterer-Siwe disease. 61
13904122 1961
255
[Abt-Letterer-Siwe disease]. 61
14494948 1961
256
A clinicopathologic study of 40 cases and review of the literature on eosinophilic granuloma of bone. Hand-Schuller-Christian disease and Letterer-Siwe disease. 61
13730162 1961
257
[Benign and malignant infantile reticulosis. Gianotti-Crosti disease. Letterer-Siwe disease]. 61
13789206 1961
258
["Bullous pneumoreticulosis". A case of the pulmonary form of the Abt-Letterer-Siwe disease]. 61
13685618 1961
259
Generalized lymphohistiocytic infiltration. A familial disease not previously described and different from Letterer-Siwe disease and Chediak-Higashi syndrome. 61
13728304 1961
260
[Letterer-Siwe disease. Presentation of an anatomoclinical case]. 61
13703494 1961
261
[A syndrome of eosinophilic granuloma, Abt-Letterer-Siwe disease and Hand-Schueller-Christian disease in an infant]. 61
13715084 1961
262
[On Abt-Letterer-Siwe disease]. 61
13704597 1961
263
[Reticulogranulomatosis and vertebra plana. Apropos of a border-line case of Letterer-Siwe disease]. 61
13772118 1961
264
[A case of Letterer-Siwe disease with slow development. (Cutaneous form with hepatosplenomegaly)]. 61
13759003 1961
265
Congenital Letterer-Siwe disease (reticuloendotheliosis) in a term stillborn infant. 61
13681769 1960
266
[Trial treatment, with 6-mercaptopurine, of a form of Letterer-Siwe disease evolving into Hand-Schueller-Christian disease in a child followed during a 4-year period]. 61
13735214 1960
267
[Contribution to the study of Abt-Letterer-Siwe disease]. 61
13687818 1960
268
[Acute reticuloendotheliosis of early childhood (Abt-Letterer-Siwe disease)]. 61
13807421 1960
269
[On the problem of Letterer-Siwe disease]. 61
13832392 1960
270
Letterer-siwe disease in a girl aged 11 years. Case report and review of literature. 61
13681064 1960
271
[Course and outcome of a case of Letterer-Siwe disease of prolonged development]. 61
13843527 1959
272
[On the problem of Letterer-Siwe disease]. 61
13805818 1959
273
[Contribution to the study of Letterer-Siwe disease]. 61
14438543 1959
274
[2 Cases of Letterer-Siwe disease]. 61
14414127 1959
275
[Letterer-Siwe disease]. 61
13832989 1959
276
Remission of Letterer-Siwe disease after prednisone therapy; report of a case. 61
13640948 1959
277
A description of eosinophilic granuloma of bone, Hand-Schüller-Christian disease, and Letterer-Siwe disease; report of a case. 61
13553314 1958
278
[Letterer-Siwe disease with prolonged evolution; development into Schüller-Christian disease]. 61
13546968 1958
279
[Letterer-Siwe disease & eosinophilic granuloma; study of 5 cases]. 61
13558926 1958
280
[Does the Abt-Letterer-Siwe disease exist]. 61
13553906 1958
281
[Letterer-Siwe disease: case report]. 61
13562759 1958
282
[Therapy and pathogenesis of Abt-Letterer-Siwe disease]. 61
13534401 1958
283
[Reticuloendotheliosis in infants; five cases of Letterer-Siwe disease]. 61
13555022 1957
284
The familial occurrence of Letterer-Siwe disease. 61
13469376 1957
285
[Case report of Abt-Letterer-Siwe disease and a review of clinical manifestations and problems of reticuloendothelioses]. 61
13456617 1957
286
Letterer-Siwe disease; report of a case. 61
13429981 1957
287
Letterer-Siwe disease treated with prednisone. 61
13431892 1957
288
The course and prognosis of reticuloendotheliosis (eosinophilic granuloma, Schüller-Christian disease and Letterer-Siwe disease); a study of forty cases. 61
13410955 1957
289
[Acute malignant reticuloendotheliosis in infants (Abt-Letterer-Siwe disease)]. 61
13452623 1957
290
Cutaneous manifestations of Letterer-Siwe disease. 61
13408443 1957
291
[Transition reticulosis: a case of eosinophilic granuloma developing into Letterer-Siwe disease]. 61
13544924 1957
292
[Case of Letterer-Siwe disease in a newborn infant]. 61
13373036 1956
293
[Letterer-Siwe disease; cutaneous and pulmonary type with icterus and ascites in a 10-month-old infant]. 61
13351684 1956
294
[Hyperacute malignant reticulosis in infant revealed by skin biopsy (Letterer-Siwe disease)]. 61
13342807 1956
295
[Existence and clinics of Abt-Letterer-Siwe disease]. 61
13321819 1956
296
Corticotrophin and cortisone in Letterer-Siwe disease and Gaucher's disease. 61
13293918 1956
297
[A case of malignant histiocytic reticulosis: Letterer-Siwe disease]. 61
13329683 1956
298
[Acute histiocyte reticulosis (Letterer-Siwe disease) with cranial lacunae having a fatal course]. 61
13328174 1956
299
Recurrent pneumonia, diarrhea, lymphadenopathy and hepatosplenomegaly in an infant surviving nine months (atypical Letterer-Siwe disease). 61
13264271 1955
300
[Case of Letterer-Siwe disease]. 61
13289189 1955
301
Discussion: eosinophilic granuloma; Letterer-Siwe disease; Hand-Schüller-Christian disease. 61
13266815 1955
302
[Relation between Abt-Letterer-Siwe disease, the eosinophilic granuloma of the bones (the eosinophilic granuloma) and Hand-Schüller-Christian disease]. 61
13253216 1955
303
[Eosinophilio granulomatosis and its relation to the Abt-Letterer-Siwe disease and the Hand-Schüller-Christian disease]. 61
13327948 1955
304
[Problem of the group diseases: eosinophilic granuloma, Hand-Schüller-Christian disease, Letterer-Siwe disease]. 61
13335563 1955
305
A case of Letterer-Siwe disease treated with cortisone. 61
13331209 1955
306
[A case of Letterer-Siwe disease in a newborn infant]. 61
13337298 1955
307
[Letterer-Siwe disease beginning in the mastoid]. 61
14388420 1955
308
Hemolytic and pancytopenic syndrome associated with Letterer-Siwe disease. 61
13214969 1954
309
Regarding the transition of a case of the Abt-Letterer-Siwe disease to lipoid granulomatosis. 61
13212601 1954
310
[Differential diagnosis of Letterer-Siwe disease from Hand-Schueller-Christian disease]. 61
13214952 1954
311
[Skin manifestations in reticuloendothelioses with special reference to the Abt-Letterer Siwe disease]. 61
13197959 1954
312
Eosinophil granuloma eosinophil granuloma, Letterer-Siwe disease and Hand-Schüller-Christian disease. 61
13201861 1954
313
Systemic reticuloendotheliosis (Letterer-Siwe disease) in the adult male. 61
13181289 1954
314
Letterer-Siwe disease: a report of two cases. 61
13212566 1954
315
[Letterer Siwe disease]. 61
13219552 1954
316
[Letterer-Siwe disease and acute reticulo-histiocytosis]. 61
13177464 1954
317
Malignant reticuloendotheliosis (Letterer-Siwe disease); report of case with normocholesteremic lipid granulomatosis and eosinophilic granuloma. 61
13137595 1